PDCD1 and pancreatic ductal adenocarcinoma: Finally, even as ICI treatments were largely ineffective in the treatment of advanced pancreatic ductal adenocarcinoma, PD-1 blockade resulted in the reactivation of circulating and tumor-infiltrating T cells as characterized by NF-kB signaling (86).